WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2026 Issue has been successfully launched on FEBRUARY 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR February 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

STUDY OF THE PREVALENCE AND RISK FACTORS OF ANTI TUBERCULOSIS DRUG INDUCED HEPATOTOXICITY AMONG PULMONARY TUBERCULOSIS PATIENTS ATTENDED AL-MADAEN GENERAL HOSPITAL IN BAGHDAD-IRAQ

*Dr. Bahaa Dawood Abdulkareem (M.B.Ch.B., C.A.B.H.S. /FM)., Dr. Huda Adnan Al-Mausawie (M.B.Ch.B., F.I.C.M.S. / FM)

ABSTRACT

Background: The first-line anti-TB drugs are potentially hepatotoxic and many factors have been reported to increase the risk of developing hepatotoxicity in patients with anti-TB therapy. Objectives: To determine the prevalence of hepatotoxicity among patients on anti-TB drug and to find any associated factors. Methods: A cross- sectional study held on 178 TB patients those admitted to Al-Madaen General hospital during the period from October 2023 to April 2024. Data were collected using a structured questionnaire, composed of socio- demographic characteristics of the patients and medical history. Data were analyzed by using Statistical Package of Social Sciences Version 29. Results: More than half (61%) of the patients were new cases, 72% of patients had no TB family history, 57% of patients use HRZE regime, 99.4% of the patient were with history of concomitant hepatotoxic drugs, 9% had abnormal liver function test with significant associations with gender, occupation and type of TB case. Conclusion: The mechanism of hepatotoxicity in female TB patients is unclear. Low socio-economic status (non-employed), and poor health TB patient were more likely to develop hepatotoxicity.

[Full Text Article] [Download Certificate]